Standout Papers

RET, ROS1 and ALK fusions in lung cancer 2009 2026 2014 2020 939
  1. RET, ROS1 and ALK fusions in lung cancer (2012)
    Kengo Takeuchi, Manabu Soda et al. Nature Medicine
  2. KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer (2009)
    Kengo Takeuchi, Young Lim Choi et al. Clinical Cancer Research

Immediate Impact

3 by Nobel laureates 17 from Science/Nature 64 standout
Sub-graph 1 of 18

Citing Papers

A vision–language foundation model for precision oncology
2025 StandoutNature
STING-induced regulatory B cells compromise NK function in cancer immunity
2022 StandoutNature
1 intermediate paper

Works of Satoko Hatano being referenced

RET, ROS1 and ALK fusions in lung cancer
2012 Standout

Author Peers

Author Last Decade Papers Cites
Satoko Hatano 1923 2509 1198 14 3.1k
Yuki Togashi 2261 3042 1507 55 4.0k
Mihaela Angelova 2298 1882 1978 18 4.6k
Hisashi Hatanaka 2684 3371 2106 24 4.8k
Munehiro Enomoto 3126 3877 2311 12 5.2k
Gladys Urbanowitz 1980 2175 1904 12 4.1k
Hannah Stubbs 1799 2056 1112 9 2.8k
Katherine Crosby 1289 1141 1581 19 2.6k
Nabila Elarouci 1471 1444 1306 20 3.1k
Laetitia Lacroix 1805 1466 1276 14 3.3k
Reimi Asaka 853 1118 736 17 1.8k

All Works

Loading papers...

Rankless by CCL
2026